The team_Conde NanoLab updated4_edited.jpg
Joao Conde_edited_edited.jpg

João Conde, PhD

  • LinkedIn Joao Conde
  • Twitter Conde NanoLab
  • Scopus
  • Publons Joao Conde
  • ORCID Joao Conde
  • ResearchGate Joao Conde
  • cienciaID Joao Conde
Joao Conde Loop Frontiers

      João Conde is an Assistant Professor and Group Leader at NOVA Medical School, ToxOmics, Nova Medical Research, Universidade Nova de Lisboa. He received his PhD in Biology, specialty in NanoBiotechnology from the NOVA University and Universidad de Zaragoza in 2014, under the FP7 European Consortium NanoScieE+ – NANOTRUCK for the development of multifunctional gold nanoparticles for gene silencing. After, he was a Marie Curie Fellow at the Massachusetts Institute of Technology, Harvard-MIT Division for Health Sciences and Technology and in School of Engineering and Materials Science, Queen Mary University of London. From 2017 to 2019 he was a Junior Investigator at Instituto de Medicina Molecular. In 2019, he won an ERC Starting Grant to build a genetic biobarcode to profile breast cancer heterogeneity. He is also co-founder of the biotech company TargTex, Targeted Therapeutics for Glioblastoma Multiforme. Since 2020, he is also part of the Global Burden of Disease (GBD) Consortium from the Institute for Health Metrics and Evaluation (IHME), University of Washington.

      The main aspects related to the recognition and diffusion of his early contributions are: nearly 90 articles in journals of Cancer Therapy, Oncology, Nanotechnology/Materials Science and NanoMedicine (The Lancet, Nature Materials, The Lancet Oncology, Nature Nanotechnology, JAMA Oncology, Nature Communications, The Lancet Gastroenterol Hepatol, Nature Rev Methods Primers, PNAS, Accounts of Chemical Research, The Lancet Child Adolesc Health, Progress in Materials Science, ACS Nano, Advanced Materials, JACS, Angewandte Chemie, Advanced Functional Materials, Trends in Cancer, Trends in Biotechnology, Biomaterials, etc.), more than 30 articles are as 1st author and more then 40 articles as corresponding author and cited more than 6500 times (h-index 41). Several of them have been selected as cover page of journals such as Nature Nanotechnology (COVID-19 Special Issue), The Lancet, The Lancet Oncology, ACS Nano, Adv. Functional Materials, Trends in Cancer, JACS, Angewandte Chemie, ACS Central Science, ACS Sensors, Biomaterials Science, ACS Applied Bio Mat, Adv. Healthcare Materials, Analytical & Bioanalytical Chemistry and BioTechniques. Moreover, 7 international patents were submitted and approved, all with relevant developments in nanomaterials-based platforms for cancer therapy and diagnosis. He was also awarded with several international awards, including the Nanomaterials 2020 Young Investigator Award, the 2021 Biomaterials Science Emerging Investigator, the Top2% Most cited in Nanoscience/Nanotechnology from PLOS Biology, the Wellcome Image Awards 2017, the Nano-Micro Letters Researcher Award, and the National Cancer Institute Image award.

Principal Investigator



Postdoctoral Researchers


Bárbara B. Mendes, PhD

      Bárbara B. Mendes has a PhD in Tissue Engineering, Regenerative Medicine & Stem Cells, from University of Minho (Portugal) in collaboration with the University of Pennsylvania (USA). She is the first-author and co-author of 9 full length papers published in international scientific journals (plus 1 under revision), 3 book chapters, 8 oral communications and 19 poster presentations. In addition, she is inventor of 1 international patent. She has an h-index of 9 according to Google Scholar, and 8 for Scopus, and her work was cited more than 250 times.
For nearly five years, she has been researching and engineering intrinsically bioactive systems as mimics of the native extracellular matrix that find multiple research and clinical applications in regenerative medicine and tissue engineering field. She is conducting research work in a multidisciplinary ground, from biomaterials, drug delivery to gene therapy.


João Conniot, PhD

      João Conniot has a Master in Pharmaceutical Sciences from the University of Lisbon (Faculty of Pharmacy). He obtained his PhD in Pharmacy in 2018, from the same University, under the supervision of Prof. Florindo from iMed.ULisboa, with a PhD scholarship from the Portuguese Foundation for Science and Technology. During his PhD studies João Conniot designed and optimized delivery systems for the co-entrapment of tumor-associated antigens and small nucleotide sequences as cancer nano-vaccines. After his PhD, João has focused on developing immune-oncology and immune-engineering approaches to improve the clinical outcomes of cancer immunotherapies. In the project GelGeneCircuit he is studying the immune cell profile within the tumor microenvironment with multicolor miRNA circuits to assess cancer therapeutic outcomes.

PhD Students


Diana Sousa, MSc

      Diana Sousa graduated in Biochemistry and obtained a Master degree in Biochemistry for Health at NOVA School of Science and Technology of the NOVA University. She worked for three years as a research fellow in different labs in the fields of Medical and Health Sciences with emphasis on Immunology, Cell Biology, Glycobiology and Cancer Therapeutics and acquired experience in antibody development and characterization, cell line manipulation and immune cell isolation/differentiation, focusing on immunomodulatory processes. She is also interested in the development of anti-cancer targeted therapeutics and diagnosis tools using nanobiomaterials and is currently pursuing her PhD in Biomedicine at the Conde Lab working on the project "Gold-nanoconjugates as an approach to target microRNAs and immune-infiltrating cells involved in lung cancer progression", which aims to develop a therapeutic strategy using gold-nanobeacons as vectors for controlled and efficient silencing of endogenous microRNAs involved in lung cancer and to evaluate its effects alone and in combination with immunomodulatory strategies.

Jhenifer Oliveira_edited.jpg

Jhenifer Oliveira, MSc

      Jhenifer Oliveira graduated in Biochemistry at NOVA School of Science and Technology – UNL in 2018. She obtained her Master's degree in Biochemistry for Health at ITQB/FCT – UNL in 2021. Her dissertation project consisted of implementing and optimizing a 3D hepatic cell model and was performed at the Advanced Cell Models laboratory – iBET, under the supervision of Doctor Catarina Brito. During this project, she acquired experience in cell culture, 3D cell culture, fluorescence microscopy, image analysis and flow cytometry data analysis.  Recently, she joined Conde Lab as a PhD student in Biomedicine and will be working on the synthesis and characterization of hybrid nanoparticles and hydrogels for local therapy of breast cancer, as well as on the evaluation of the therapeutic efficacy and the profiling of tumour heterogeneity.

Master Students

Joana Amorim_edited.jpg

Joana Amorim, BSc

      Joana Amorim graduated in Health Sciences at the University of Lisbon in 2020. Currently, she is pursuing her master's degree in Biomedical Research with a specialization in oncobiology at NOVA Medical School of NOVA University. Joana has acquired a great interest in precision medicine for cancer treatment. For her thesis project, she will be focusing on the development of polymeric nanoparticles for the delivery of miRNA cassettes as part of the ERC project " Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits".

Research Scholar

Joao Ravasco_edited.jpg

João Ravasco, MSc

      João M. Ravasco received his M. Pharma from the Faculty of Pharmacy of the University of Lisbon (FFUL). He is currently finishing his PhD student at iMed.ULisboa under the supervision of Prof. Carlos A. M. Afonso and Dr. Alexandre Trindade. During his PhD, João has been studying the reactivity profile and designing controllable bioorthogonal tools for bioconjugation and controlled drug delivery. For such purpose, he has also established comprehensive multivariate AI models predicting the efficacy of gold-standard bioorthogonal cycloadditions in biological systems. Currently, he is interested in developing multifunctional systems for cancer therapy and profiling.



Rajendra Prasad, PhD

Now @Tufts University, Boston US - Nanomedicine Investigator & Postdoctoral Fellow